Literature DB >> 16361732

Childhood bullous pemphigoid successfully treated with diaminodiphenyl sulfone.

Sei-Ichiro Motegi1, Masatoshi Abe, Atsushi Tamura, Norito Ishii, Takashi Hashimoto, Osamu Ishikawa.   

Abstract

Bullous pemphigoid (BP) is an acquired autoimmune blistering disease which predominantly affects the elderly. It is rare in children and infants. We reported a 14-year-old girl presenting with a month history of relapsing tense bullae on the face and extremities. Histopathological examination of the lesional skin revealed a subepidermal bulla with infiltration of eosinophils, neutrophils, and lymphocytes. Direct immunofluorescence showed linear deposits of IgM and C3 at the basement membrane zone. Indirect immunofluorescence using normal human skin sections as a substrate detected IgG anti-basement membrane zone antibodies in the patient's serum and that using 1M NaCl split skin sections showed that the patient's antibodies bound to the epidermal side of the split skin. Immunoblot analysis using normal human epidermal extracts demonstrated the presence of autoantibodies against the 230-kDa BP antigen. Furthermore, the patient's serum reacted with the recombinant protein of the NC16a domain of the 180-kDa BP antigen by immunoblot analysis and enzyme-linked immunosorbent assay. Our patient showed significant improvement of the skin lesions with systemic administration of diaminodiphenyl sulfone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16361732     DOI: 10.1111/j.1346-8138.2005.tb00849.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  2 in total

Review 1.  Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms.

Authors:  Connor Cole; Keshavamurthy Vinay; Luca Borradori; Kyle T Amber
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

2.  Dyshidrosiform pemphigoid localized on the hands in a child: a rare occurrence.

Authors:  Surabhi Dayal; Priyadarshini Sahu; Vijay Kumar Jain
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.